These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 21643487)

  • 21. Cell-specific induction of apoptosis by rationally designed bivalent aptamer-siRNA transcripts silencing eukaryotic elongation factor 2.
    Wullner U; Neef I; Eller A; Kleines M; Tur MK; Barth S
    Curr Cancer Drug Targets; 2008 Nov; 8(7):554-65. PubMed ID: 18991566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Silico Selection of Gp120 ssDNA Aptamer to HIV-1.
    Sepehri Zarandi H; Behbahani M; Mohabatkar H
    SLAS Discov; 2020 Oct; 25(9):1087-1093. PubMed ID: 32452249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents.
    Kim M; Kim DM; Kim KS; Jung W; Kim DE
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29617327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small Interfering RNAs and their Delivery Systems: A Novel Powerful Tool for the Potential Treatment of HIV Infections.
    Bolhassani A; Milani A
    Curr Mol Pharmacol; 2020; 13(3):173-181. PubMed ID: 31760929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA.
    Fattal E; Bochot A
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1203-23. PubMed ID: 17097190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras.
    Wheeler LA; Trifonova R; Vrbanac V; Basar E; McKernan S; Xu Z; Seung E; Deruaz M; Dudek T; Einarsson JI; Yang L; Allen TM; Luster AD; Tager AM; Dykxhoorn DM; Lieberman J
    J Clin Invest; 2011 Jun; 121(6):2401-12. PubMed ID: 21576818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blocking interaction of viral gp120 and CD4-expressing T cells by single-stranded DNA aptamers.
    Zhao N; Pei SN; Parekh P; Salazar E; Zu Y
    Int J Biochem Cell Biol; 2014 Jun; 51():10-8. PubMed ID: 24661998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methods for Evaluating Cell-Specific, Cell-Internalizing RNA Aptamers.
    Hernandez LI; Flenker KS; Hernandez FJ; Klingelhutz AJ; McNamara JO; Giangrande PH
    Pharmaceuticals (Basel); 2013 Mar; 6(3):295-319. PubMed ID: 23894227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of aptamers in diagnostics, drug-delivery and imaging.
    Chandola C; Kalme S; Casteleijn MG; Urtti A; Neerathilingam M
    J Biosci; 2016 Sep; 41(3):535-61. PubMed ID: 27581942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-specific aptamer-mediated targeted drug delivery.
    Zhou J; Rossi JJ
    Oligonucleotides; 2011 Feb; 21(1):1-10. PubMed ID: 21182455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aptamer delivery of siRNA, radiopharmaceutics and chemotherapy agents in cancer.
    de Almeida CEB; Alves LN; Rocha HF; Cabral-Neto JB; Missailidis S
    Int J Pharm; 2017 Jun; 525(2):334-342. PubMed ID: 28373101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted delivery of short interfering RNAs--strategies for in vivo delivery.
    Wullner U; Neef I; Tur MK; Barth S
    Recent Pat Anticancer Drug Discov; 2009 Jan; 4(1):1-8. PubMed ID: 19149683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multivalent comb-type aptamer-siRNA conjugates for efficient and selective intracellular delivery.
    Yoo H; Jung H; Kim SA; Mok H
    Chem Commun (Camb); 2014 Jun; 50(51):6765-7. PubMed ID: 24830507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aptamer-targeted cell-specific RNA interference.
    Zhou J; Rossi JJ
    Silence; 2010 Feb; 1(1):4. PubMed ID: 20226078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new nucleic acid-based agent inhibits cytotoxic T lymphocyte-mediated immune disorders.
    Wang CW; Chung WH; Cheng YF; Ying NW; Peck K; Chen YT; Hung SI
    J Allergy Clin Immunol; 2013 Sep; 132(3):713-722.e11. PubMed ID: 23791505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted siRNA delivery using aptamer-siRNA chimeras and aptamer-conjugated nanoparticles.
    Sivakumar P; Kim S; Kang HC; Shim MS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 May; 11(3):e1543. PubMed ID: 30070426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aptamer-targeted RNAi for HIV-1 therapy.
    Zhou J; Rossi JJ
    Methods Mol Biol; 2011; 721():355-71. PubMed ID: 21431697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in siRNA delivery.
    Sarisozen C; Salzano G; Torchilin VP
    Biomol Concepts; 2015 Dec; 6(5-6):321-41. PubMed ID: 26609865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rabies Prophylactic and Treatment Options: An In Vitro Study of siRNA- and Aptamer-Based Therapeutics.
    Scott TP; Nel LH
    Viruses; 2021 May; 13(5):. PubMed ID: 34064911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The aptamer-siRNA conjugates: reprogramming T cells for cancer therapy.
    Sakib Hossain DM; Duttagupta P; Kortylewski M
    Ther Deliv; 2015 Jan; 6(1):1-4. PubMed ID: 25565435
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.